These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11283809)

  • 1. Prophylactic antifungal therapy in the intensive care unit.
    Rex JH; Sobel JD
    Clin Infect Dis; 2001 Apr; 32(8):1191-200. PubMed ID: 11283809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.
    Vardakas KZ; Samonis G; Michalopoulos A; Soteriades ES; Falagas ME
    Crit Care Med; 2006 Apr; 34(4):1216-24. PubMed ID: 16484923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal treatment strategies in high risk patients.
    Rüping MJ; Vehreschild JJ; Cornely OA
    Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical critical care: fungal infections in surgical patients.
    Lipsett PA
    Crit Care Med; 2006 Sep; 34(9 Suppl):S215-24. PubMed ID: 16917426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
    Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit.
    Smith JA; Kauffman CA
    Crit Care Med; 2010 Aug; 38(8 Suppl):S380-7. PubMed ID: 20647796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
    Shah T; Lai WK; Gow P; Leeming J; Mutimer D
    Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical consequences of resistant Candida infections in intensive care.
    Montravers P; Jabbour K
    Int J Antimicrob Agents; 2006 Jan; 27(1):1-6. PubMed ID: 16343859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current options for antifungal therapy of invasive candidiasis in intensive care units].
    Hamal P; Raclavský V; Svobodová L; Koukalová D
    Klin Mikrobiol Infekc Lek; 2010 Oct; 16(5):164-70. PubMed ID: 21191874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
    Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of antifungal prophylaxis among patients in surgical intensive care units: concepts and considerations.
    Lipsett PA
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S193-9. PubMed ID: 15546117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial prophylaxis in febrile neutropenia.
    Yoshida M; Ohno R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of candidiasis in the intensive care unit.
    Schelenz S
    J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i31-4. PubMed ID: 18063602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit.
    Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N
    Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early antifungal intervention strategies in ICU patients.
    Eggimann P; Ostrosky-Zeichner L
    Curr Opin Crit Care; 2010 Oct; 16(5):465-9. PubMed ID: 20827073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
    Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
    Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure.
    Weitkamp JH; Ozdas A; LaFleur B; Potts AL
    J Perinatol; 2008 Jun; 28(6):405-11. PubMed ID: 18185518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.